11/5
08:12 am
hura
TuHURA Biosciences (NASDAQ: HURA) is now covered by analysts at Maxim Group. They set a "buy" rating and a $15.00 price target on the stock.
Medium
Report
TuHURA Biosciences (NASDAQ: HURA) is now covered by analysts at Maxim Group. They set a "buy" rating and a $15.00 price target on the stock.
10/23
08:30 am
hura
TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
Low
Report
TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
10/22
09:00 am
hura
TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor "New to the Street" Event
Medium
Report
TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor "New to the Street" Event
10/17
04:35 pm
hura
TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics
High
Report
TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics